Records 1-5 (of 5 Records) |
Query Trace: Telomeres[original query] |
---|
An evidence-based debate on epigenetics and immunosenescence in COVID-19. Napoli Claudio, et al. Current research in immunology 2023 0 0. 100069 |
Telomere Shortening and Its Association with Cell Dysfunction in Lung Diseases. Ruiz Andy, et al. International journal of molecular sciences 2022 0 0. (1) |
TELO-SCOPE study: a randomised, double-blind, placebo-controlled, phase 2 trial of danazol for short telomere related pulmonary fibrosis. Mackintosh John A, et al. BMJ open respiratory research 2021 0 0. (1) |
Short Telomeres and a T-Cell Shortfall in COVID-19: The Aging Effect. Anderson James J, et al. medRxiv : the preprint server for health sciences 2021 0 0. |
Shorter telomere lengths in patients with severe COVID-19 disease. Sanchez-Vazquez Raul et al. Aging 2021 Jan |
Disclaimer: Articles listed in the Public Health
Knowledge Base are selected by the CDC Office of Public Health
Genomics to provide current awareness of the literature and news.
Inclusion in the update does not necessarily represent the views of
the Centers for Disease Control and Prevention nor does it imply
endorsement of the article's methods or findings. CDC and DHHS assume
no responsibility for the factual accuracy of the items presented. The
selection, omission, or content of items does not imply any
endorsement or other position taken by CDC or DHHS. Opinion, findings
and conclusions expressed by the original authors of items included in
the update, or persons quoted therein, are strictly their own and are
in no way meant to represent the opinion or views of CDC or DHHS.
References to publications, news sources, and non-CDC Websites are
provided solely for informational purposes and do not imply
endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 17, 2024
- Content source: